FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, in particular to medication for treatment of remote effects of poisoning by methemoglobin generators. Medication for treatment of remote effects of poisoning by methemoglobin generators, including dry extract of fruits and seeds of Schisandra (standardised by content of total amount of lignans not less than 2.5%) and cytoflavin, taken in definite ratio.
EFFECT: medication is efficient for treatment of remote effects of poisoning by methemoglobin generators.
6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIHYPOXYC AGENT FOR TREATING REMOTE CONSEQUENCES OF METHEMOGLOBIN FORMER POISONINGS | 2008 |
|
RU2392958C2 |
| PHARMACEUTICAL COMPOSITION OF PEDIPHENE FOR TREATING DAMAGE BY NON-LETHAL IRRITANTS | 2012 |
|
RU2496485C1 |
| HEMOSTIMULANT AND PHARMACEUTICAL COMPOSITION AND METHOD FOR HEMOPOIESIS STIMULATION | 2011 |
|
RU2482869C1 |
| COMPONENT COMPOSITION "ADAPTOVIT" SHOWING ANTIHYPOXIC EFFECT | 1997 |
|
RU2114628C1 |
| ANTICONVULSIVE MEDICATION | 2007 |
|
RU2355390C1 |
| AGENT HAVING ANTI-OXIDANT, ANTI-INFLAMMATORY, NEUROPROTECTIVE, HYPOLIPIDEMIC, HYPOCHOLESTEROLEMIC, HYPOGLYCEMIC, HEPATOPROTECTIVE AND IMMUNOSUPPRESSIVE ACTIVITY | 2012 |
|
RU2487884C1 |
| METHOD OF PRODUCING AN AGENT POSSESSING ADAPTOGENIC ACTIVITY | 2018 |
|
RU2695335C1 |
| COMPOSITION OPTIMIZING CELL VITAL ACTIVITY AND THE HOST CELLULAR SYSTEMS UNDER UNFAVORABLE CONDITIONS | 1997 |
|
RU2121852C1 |
| ANTIMUTAGEN | 2004 |
|
RU2266128C1 |
| PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
